Pulmonary Hypertension - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Updated clinical classification of pulmonary hypertension
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association
Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
The right ventricle in pulmonary hypertension
Pulmonary hypertension is associated with an increased incidence of NAFLD: A retrospective cohort study of 18,910 patients
Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease
Pulmonary hypertension related to congenital heart disease: a call for action
Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry
A Case of Pulmonary Hypertension Associated with Idiopathic Hypereosinophilic Syndrome
Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience

|<< 1 2 3 4 5 6 7 8 >>|

Review Article

2013 Dec 24;62(25 Suppl):D34-41.

JOURNAL：J Am Coll Cardiol.

Article Link

Updated clinical classification of pulmonary hypertension

Simonneau G, Gatzoulis MA, Adatia I et al.

3693

Keywords: CHD; HAART; HIV; IFN; PAH; PAP; PH; PH due to chronic lung diseases; PH due to left heart disease; POPH; PPHN; PVR; SCD; Sch-PAH; TGF; TKI; chronic thromboembolic pulmonary hypertension; congenital heart disease; highly active antiretroviral therapy; human immunodeficiency virus; interferon; persistent pulmonary hypertension of the newborn; portopulmonary hypertension; pulmonary arterial hypertension; pulmonary arterial pressure; pulmonary hypertension; pulmonary vascular resistance; schistosomiasis-associated PAH; sickle cell disease; tumor growth factor; tyrosine kinase inhibitor

FULL TEXT PDF